Optimal scientific interpretation of translational research requires careful data and sample collection that is analyzed with basic science techniques, correlated to human outcomes, and the knowledge gained translated back to clinical care (e.g. bench-to-bedside research). Critical to this process are 1.) accurate validation that the clinical information collected is correct and that the data are handled, categorized, maintained, and analyzed accurately;and 2.) a need for high quality specimens of various types, including blood and tissue samples. Therefore, the goal of this Core is to provide a central repository for clinical data and subject samples for use in the scientific projects of this program project using careful selection and data categorization with fundamental integration with the Project and Core Pis at all experimental phases ncluding study and database design, sample size determination, data collection, and final analysis. This is a novel resource in its scope and detail for thyroid cancer and collection of unique samples and datapoints specifically organized for support of this P-01 proposal. In support of this objective, the Specific Aims of the Integrated Clinical Information &Pathology Sample Repository Core (Core A) include: 1. Creation of a human data repository of clinical information including subject diagnosis, treatment, pathology (including AJCC cancer staging parameters), tumor markers, and detailed family history. 2. Creation of human subjects'germline sample repository collected from biological samples (blood, buccal swabs, and/or saliva). 3. Creation of a thyroid tissue bank to include fine needle aspiration (FNA), fresh frozen and paraffin embedded thyroid tissue (tumor and matching normal) and non-medullary thyroid cancer tissue microarrays (TMA).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA124570-05
Application #
8378704
Study Section
Special Emphasis Panel (ZCA1-GRB-S)
Project Start
Project End
2013-04-29
Budget Start
2012-03-01
Budget End
2013-02-28
Support Year
5
Fiscal Year
2012
Total Cost
$328,317
Indirect Cost
$93,914
Name
Ohio State University
Department
Type
DUNS #
832127323
City
Columbus
State
OH
Country
United States
Zip Code
43210
Nabhan, Fadi; Ringel, Matthew D (2016) Thyroid nodules and cancer management guidelines: comparisons and controversies. Endocr Relat Cancer :
Shirley, Lawrence A; McCarty, Samantha; Yang, Ming-Chen et al. (2016) Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target. Surgery 159:163-70
Tomsic, Jerneja; Fultz, Rebecca; Liyanarachchi, Sandya et al. (2016) HABP2 G534E Variant in Papillary Thyroid Carcinoma. PLoS One 11:e0146315
Harshman, Sean W; Canella, Alessandro; Ciarlariello, Paul D et al. (2016) Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. J Proteomics 136:89-98
Kirschner, Lawrence S; Qamri, Zahida; Kari, Suresh et al. (2016) Mouse models of thyroid cancer: A 2015 update. Mol Cell Endocrinol 421:18-27
Justiniano, Steven E; McElroy, Joseph P; Yu, Lianbo et al. (2016) Genetic variants in thyroid cancer distant metastases. Endocr Relat Cancer 23:L33-6
Wang, Yanqiang; Li, Wei; Phay, John E et al. (2016) Primary Cell Culture Systems for Human Thyroid Studies. Thyroid 26:1131-40
Nagy, Rebecca; Ringel, Matthew D (2015) Genetic predisposition for nonmedullary thyroid cancer. Horm Cancer 6:13-20
Yehia, Lamis; Niazi, Farshad; Ni, Ying et al. (2015) Germline Heterozygous Variants in SEC23B Are Associated with Cowden Syndrome and Enriched in Apparently Sporadic Thyroid Cancer. Am J Hum Genet 97:661-76
Tomsic, Jerneja; He, Huiling; de la Chapelle, Albert (2015) HABP2 Mutation and Nonmedullary Thyroid Cancer. N Engl J Med 373:2086

Showing the most recent 10 out of 101 publications